A UV-independent pathway to melanoma carcinogenesis in the redhair-fairskin background

People with pale skin, red hair, freckles and an inability to tan—the ‘red hair/fair skin’ phenotype—are at highest risk of developing melanoma, compared to all other pigmentation types. Genetically, this phenotype is frequently the product of inactivating polymorphisms in the melanocortin 1 receptor (MC1R) gene. MC1R encodes a cyclic AMP-stimulating G-protein-coupled receptor that controls pigment production. Minimal receptor activity, as in red hair/fair skin polymorphisms, produces the red/yellow pheomelanin pigment, whereas increasing MC1R activity stimulates the production of black/brown eumelanin. Pheomelanin has weak shielding capacity against ultraviolet radiation relative to eumelanin, and has been shown to amplify ultraviolet-A-induced reactive oxygen species. Several observations, however, complicate the assumption that melanoma risk is completely ultraviolet-radiation-dependent. For example, unlike non-melanoma skin cancers, melanoma is not restricted to sun-exposed skin and ultraviolet radiation signature mutations are infrequently oncogenic drivers. Although linkage of melanoma risk to ultraviolet radiation exposure is beyond doubt, ultraviolet-radiation-independent events are likely to have a significant role. Here we introduce a conditional, melanocyte-targeted allele of the most common melanoma oncoprotein, BRAFV600E, into mice carrying an inactivating mutation in the Mc1r gene (these mice have a phenotype analogous to red hair/fair skin humans). We observed a high incidence of invasive melanomas without providing additional gene aberrations or ultraviolet radiation exposure. To investigate the mechanism of ultraviolet-radiation-independent carcinogenesis, we introduced an albino allele, which ablates all pigment production on the Mc1re/e background. Selective absence of pheomelanin synthesis was protective against melanoma development. In addition, normal Mc1re/e mouse skin was found to have significantly greater oxidative DNA and lipid damage than albino-Mc1re/e mouse skin. These data suggest that the pheomelanin pigment pathway produces ultraviolet-radiation-independent carcinogenic contributions to melanomagenesis by a mechanism of oxidative damage. Although protection from ultraviolet radiation remains important, additional strategies may be required for optimal melanoma prevention.

[1]  Ian Jackson,et al.  Variants of the melanocyte–stimulating hormone receptor gene are associated with red hair and fair skin in humans , 1995, Nature Genetics.

[2]  J. Shay,et al.  BRAFE600-associated senescence-like cell cycle arrest of human naevi , 2005, Nature.

[3]  J. Mark Elwood,et al.  Melanoma and sun exposure: An overview of published studies , 1997, International journal of cancer.

[4]  K. Wakamatsu,et al.  Melanocortin 1 receptor genotype: an important determinant of the damage response of melanocytes to ultraviolet radiation , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  M. Dizdaroglu,et al.  8,5'-Cyclopurine-2'-deoxynucleosides in DNA: mechanisms of formation, measurement, repair and biological effects. , 2008, DNA repair.

[6]  Yinsheng Wang,et al.  High-throughput analysis of the mutagenic and cytotoxic properties of DNA lesions by next-generation sequencing , 2011, Nucleic acids research.

[7]  A. L. Kadekaro,et al.  MC1R and the response of melanocytes to ultraviolet radiation. , 2005, Mutation research.

[8]  Yinsheng Wang,et al.  Bulky DNA lesions induced by reactive oxygen species. , 2008, Chemical research in toxicology.

[9]  R. DePinho,et al.  BRafV600E cooperates with Pten silencing to elicit metastatic melanoma , 2009, Nature Genetics.

[10]  Yinsheng Wang,et al.  Quantification of oxidative DNA lesions in tissues of Long-Evans Cinnamon rats by capillary high-performance liquid chromatography-tandem mass spectrometry coupled with stable isotope-dilution method. , 2011, Analytical chemistry.

[11]  J. Reis-Filho,et al.  (V600E)Braf::Tyr-CreERT2::K14-Kitl mice do not develop superficial spreading-like melanoma: keratinocyte Kit ligand is insufficient to "translocate" (V600E)Braf-driven melanoma to the epidermis. , 2012, The Journal of investigative dermatology.

[12]  D. Fisher,et al.  Topical drug rescue strategy and skin protection based on the role of Mc1r in UV-induced tanning , 2006, Nature.

[13]  J. Nadeau,et al.  Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function , 1993, Cell.

[14]  L. Zon,et al.  BRAF Mutations Are Sufficient to Promote Nevi Formation and Cooperate with p53 in the Genesis of Melanoma , 2005, Current Biology.

[15]  John D Simon,et al.  Aggregation of eumelanin mitigates photogeneration of reactive oxygen species. , 2002, Free radical biology & medicine.

[16]  M. Weinstock,et al.  Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals. , 1989, JAMA.

[17]  B. Kwon,et al.  Tyrosinases of murine melanocytes with mutations at the albino locus. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[18]  K. Flaherty,et al.  Selective BRAFV600E inhibition enhances T-cell recognition of melanoma without affecting lymphocyte function. , 2010, Cancer research.

[19]  A. Neugut,et al.  Black-white differences in risk for cutaneous, ocular, and visceral melanomas. , 1994, American journal of public health.

[20]  G J Hill,et al.  UVA, pheomelanin and the carcinogenesis of melanoma. , 2000, Pigment cell research.

[21]  N. Ibrahim,et al.  Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice , 2009, Oncogene.

[22]  J. Reis-Filho,et al.  Oncogenic Braf induces melanocyte senescence and melanoma in mice. , 2009, Cancer cell.

[23]  Bruce Kupelnick,et al.  Use of topical sunscreens and the risk of malignant melanoma: a meta-analysis of 9067 patients from 11 case-control studies. , 2002, American journal of public health.

[24]  J. Fridlyand,et al.  Distinct sets of genetic alterations in melanoma. , 2005, The New England journal of medicine.

[25]  E. Wenczl,et al.  (Pheo)melanin photosensitizes UVA-induced DNA damage in cultured human melanocytes. , 1998, The Journal of investigative dermatology.

[26]  S. Nishikawa,et al.  Murine Cutaneous Mastocytosis and Epidermal Melanocytosis Induced by Keratinocyte Expression of Transgenic Stem Cell Factor , 1998, The Journal of experimental medicine.

[27]  Gail M Williams,et al.  Reduced melanoma after regular sunscreen use: randomized trial follow-up. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  M. Tucker,et al.  Melanoma induction by ultraviolet A but not ultraviolet B radiation requires melanin pigment , 2012, Nature Communications.

[29]  E. Flori,et al.  The eumelanin intermediate 5,6-dihydroxyindole-2-carboxylic acid is a messenger in the cross-talk among epidermal cells. , 2012, The Journal of investigative dermatology.

[30]  K. Wakamatsu,et al.  Stem cell factor rescues tyrosinase expression and pigmentation in discreet anatomic locations in albino mice , 2009, Pigment cell & melanoma research.